BEDFORD, MA--(Marketwire - December 3, 2010) -  Insulet Corporation (NASDAQ: PODD), the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, today announced the Company will participate in the Canaccord 5th Annual Cardiovascular, Diabetes and Obesity Conference at the Nikko Hotel in San Francisco. Management is scheduled to present an overview of the Company on Wednesday, December 8, 2010 at 11:00 a.m. P.T. (2:00 p.m. E.T.). 

During the presentations, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to the audio webcast of the presentation during the events, please visit: A replay of the webcasts will be available for 30 days.

About Insulet Corporation

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA. For more information, please visit:

Contact Information:

Stephanie Marks for Insulet Corporation